These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 21553300)

  • 21. Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.
    Zelaya MV; Pérez-Valderrama E; de Morentin XM; Tuñon T; Ferrer I; Luquin MR; Fernandez-Irigoyen J; Santamaría E
    Oncotarget; 2015 Nov; 6(37):39437-56. PubMed ID: 26517091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease and alpha-synuclein pathology in the olfactory bulbs of infants, children, teens and adults ≤ 40 years in Metropolitan Mexico City. APOE4 carriers at higher risk of suicide accelerate their olfactory bulb pathology.
    Calderón-Garcidueñas L; González-Maciel A; Reynoso-Robles R; Kulesza RJ; Mukherjee PS; Torres-Jardón R; Rönkkö T; Doty RL
    Environ Res; 2018 Oct; 166():348-362. PubMed ID: 29935448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of olfactory bulb pathology on olfactory function in normal aging.
    Tremblay C; Serrano GE; Intorcia AJ; Sue LI; Wilson JR; Adler CH; Shill HA; Driver-Dunckley E; Mehta SH; Beach TG
    Brain Pathol; 2022 Sep; 32(5):e13075. PubMed ID: 35485279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
    Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
    Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.
    Deramecourt V; Bombois S; Maurage CA; Ghestem A; Drobecq H; Vanmechelen E; Lebert F; Pasquier F; Delacourte A
    J Neuropathol Exp Neurol; 2006 Mar; 65(3):278-88. PubMed ID: 16651889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease.
    Kovács T; Cairns NJ; Lantos PL
    Neuropathol Appl Neurobiol; 1999 Dec; 25(6):481-91. PubMed ID: 10632898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex.
    Winton MJ; Joyce S; Zhukareva V; Practico D; Perl DP; Galasko D; Craig U; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 May; 111(5):401-12. PubMed ID: 16609851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olfactory Bulb Integrity in Frontotemporal Dementia and Alzheimer's Disease.
    Carnemolla SE; Kumfor F; Liang CT; Foxe D; Ahmed RM; Piguet O
    J Alzheimers Dis; 2022; 89(1):51-66. PubMed ID: 35848020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staging of alpha-synuclein in the olfactory bulb in a model of Parkinson's disease: cell types involved.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Mohedano-Moriano A; Fradejas N; Calvo S; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
    Mov Disord; 2010 Aug; 25(11):1701-7. PubMed ID: 20574962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. α-Synuclein in the olfactory system of a mouse model of Parkinson's disease: correlation with olfactory projections.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Martinez-Marcos A
    Brain Struct Funct; 2012 Apr; 217(2):447-58. PubMed ID: 21928152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiprotein deposits in neurodegenerative disorders: our experience in the tissue brain bank of Navarra.
    Echávarri C; Caballero MC; Aramendía A; García-Bragado F; Tuñón T
    Anat Rec (Hoboken); 2011 Jul; 294(7):1191-7. PubMed ID: 21618706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variability and heterogeneity in Alzheimer's disease with cotton wool plaques: a clinicopathological study of four autopsy cases.
    Yokota O; Terada S; Ishizu H; Ujike H; Ishihara T; Namba M; Hayashi Y; Nishinaka T; Namba R; Nakashima H; Uéda K; Checler F; Kuroda S
    Acta Neuropathol; 2003 Oct; 106(4):348-56. PubMed ID: 12883830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies.
    Fujishiro H; Tsuboi Y; Lin WL; Uchikado H; Dickson DW
    Acta Neuropathol; 2008 Jul; 116(1):17-24. PubMed ID: 18446351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19.
    Lengacher NA; Tomlinson JJ; Jochum AK; Franz J; Hasan Ali O; Flatz L; Jochum W; Penninger J; ; Stadelmann C; Woulfe JM; Schlossmacher MG
    Acta Neuropathol Commun; 2024 May; 12(1):70. PubMed ID: 38698465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
    Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
    Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
    Jellinger KA
    Acta Neuropathol; 2009 Feb; 117(2):215-6; author reply 217-8. PubMed ID: 18985364
    [No Abstract]   [Full Text] [Related]  

  • 37. Correlations between cortical and subcortical tau pathology.
    Attems J; Thomas A; Jellinger K
    Neuropathol Appl Neurobiol; 2012 Oct; 38(6):582-90. PubMed ID: 22115520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
    Beach TG; White CL; Hladik CL; Sabbagh MN; Connor DJ; Shill HA; Sue LI; Sasse J; Bachalakuri J; Henry-Watson J; Akiyama H; Adler CH;
    Acta Neuropathol; 2009 Feb; 117(2):169-74. PubMed ID: 18982334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.
    Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN
    Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linker histone H1 binds to disease associated amyloid-like fibrils.
    Duce JA; Smith DP; Blake RE; Crouch PJ; Li QX; Masters CL; Trounce IA
    J Mol Biol; 2006 Aug; 361(3):493-505. PubMed ID: 16854430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.